SCHEMBL57365

SCHEMBL57365

Cc1ccc(-c2c3ccccc3c(Br)c3ccccc23)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.54
CYP2A6 P11509 3/20 0.42
MAPT P10636 4/20 0.38
KDM4E B2RXH2 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PABPC1 P11940 1/20 0.38
ALDH1A1 P00352 6/20 0.37
HIF1A Q16665 3/20 0.36
EPAS1 Q99814 3/20 0.36
TDP1 Q9NUW8 3/20 0.36
CES2 O00748 2/20 0.36
KDM1A O60341 2/20 0.36
CES1 P23141 2/20 0.36
PTPN6 P29350 2/20 0.36
BLM P54132 2/20 0.36
PTPN11 Q06124 2/20 0.36
EED O75530 1/20 0.36
POLB P06746 1/20 0.36
SUZ12 Q15022 1/20 0.36
EZH2 Q15910 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL260441 0.89 CYP1A2 (0.68) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2
SCHEMBL29416731 0.89 CYP1A2 (0.68) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2
SCHEMBL2380918 0.89 CYP1A2 (0.68) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2
SCHEMBL4264420 0.87 POLB (0.34) CYP1A2CYP2A6MAPTKDM4EALDH1A1
SCHEMBL13978976 0.84 POLB (0.33) CYP1A2MAPTKDM4EALDH1A1HIF1A
SCHEMBL12781870 0.81 ALDH1A1 (0.41) CYP1A2CYP2A6SMN1; SMN2ALDH1A1TSHR
SCHEMBL18567994 0.79 CYP1A2 (0.54) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2
SCHEMBL9612421 0.79 CYP1A2 (0.38) CYP1A2CYP2A6MAPTKDM4EALDH1A1
SCHEMBL15854457 0.78 CYP1A2 (0.39) CYP1A2MAPTALDH1A1POLBLMNA
SCHEMBL701595 0.77 ALDH1A1 (0.35) CYP1A2CYP2A6MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3287506-B1 PHENANTHRENE DERIVATIVES MERCK PATENT GMBH (DE) 2020-02-26 EP disclosed
EP-1797158-B1 PHENANTHRENE DERIVATIVES MERCK PATENT GMBH (DE) 2019-05-01 EP disclosed
EP-3287506-A1 PHENANTHRENE DERIVATIVES Merck Patent GmbH (DE) 2018-02-28 EP disclosed
US-9893292-B2 Materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2018-02-13 US disclosed
US-9893292-B2 Materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2018-02-13 US disclosed
US-9871213-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2018-01-16 US disclosed
US-9871213-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2018-01-16 US disclosed
US-9871213-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2018-01-16 US disclosed
EP-1888707-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2017-08-09 EP disclosed
EP-1888706-B1 ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN MERCK PATENT GMBH (DE) 2017-03-01 EP disclosed
US-20080166593-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
CN-101171320-A Organic electroluminescent device MERCK PATENT GMBH (DE) 2008-04-30 CN disclosed
CN-101155896-A Organic electroluminescent device MERCK PATENT GMBH (DE) 2008-04-02 CN disclosed
EP-1888706-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN Merck Patent GmbH (DE) 2008-02-20 EP disclosed
EP-1871856-A1 ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2008-01-02 EP disclosed
CN-101068905-A Phenanthrene derivative MERCK PATENT GMBH (DE) 2007-11-07 CN disclosed
EP-1797158-A1 PHENANTHRENE DERIVATIVE Merck Patent GmbH (DE) 2007-06-20 EP disclosed
WO-2006117052-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN MERCK PATENT GMBH (DE) 2006-11-09 WO disclosed
WO-2006108498-A1 ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2006-10-19 WO disclosed
WO-2006039982-A1 PHENANTHRENE DERIVATIVE MERCK PATENT GMBH (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166593-A1 Organic Electroluminescent Devices OR10J3, DDT, EML4 CYP1A2 870/4885CYP2A6 1909/4885MAPT 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.